References
- Jha AK, Suchismita A, Jha RK, et al. Spectrum of gastrointestinal involvement in Stevens – Johnson syndrome. World J Gastrointest Endosc. 2019;11(2):115–123.
- Tran AK, Sidhu S. Stevens Johnson syndrome and toxic epidermal necrolysis – an Australian analysis of treatment outcomes and mortality. J Dermatolog Treat. 2019;30(7):718–723.
- Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019–1024.
- (a) Majima Y, Ikeda Y, Yagi H, et al. Colonic involvement in Stevens-Johnson syndrome-like mucositis without skin lesions. Allergol Int. 2015;64(1):106–108. (b) Brown CS, Defazio JR, An G, et al. Toxic epidermal necrolysis with gastrointestinal involvement: a case report and review of the literature. J Burn Care Res. 2017;38:e450–e455.
- Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Cur Manage J Crohn’s Colitis. 2017;11(7):769–784.
- Saniabadi AR, Tanaka T, Yamamoto T, et al. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: concepts and clinical features for better therapeutic outcomes. J Clin Apher. 2019;34(1):51–60.
- Sjoberg F, Singer M. The medical use of oxygen: a time for critical reappraisal. J Intern Med. 2013;274(6):505–528.
- Pelaseyed T, Bergstrom JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8–20.
- Becker E, Schmidt TSB, Bengs S, et al. Effects of oral antibiotics and isotretinoin on the murine gut microbiota. Int J Antimicrob Agents. 2017;50(3):342–351.